Skip to content

Platform
- Overview
- Publications
Pipeline
About
Investors
Careers
Contact

Platform
- Overview
- Publications
Pipeline
About
Investors
Careers
Contact

Platform:
Publications

man working - Alto publications hero

Leveraging clinical and biological insights to drive innovation in psychiatry

See our publications, presentations, and more to discover the revolutionary potential of our precision approach.

Choose Resource Type
Choose Focus Area
Search Resources

Found 47 Results

August 27, 2020

The effects of roflumilast, a phosphodiesterase type-4 inhibitor, on EEG biomarkers in schizophrenia: A randomised controlled trial

July 14, 2020

Phosphodiesterase-4 enzyme as a therapeutic target in neurological disorders

April 1, 2020

An electroencephalographic signature predicts antidepressant response in major depression

February 13, 2020

Global connectivity and local excitability changes underlie antidepressant effects of repetitive transcranial magnetic stimulation

January 22, 2020

An Electroencephalography Connectomic Profile of Posttraumatic Stress Disorder

January 2, 2020

Cortical Connectivity Moderators of Antidepressant vs Placebo Treatment Response in Major Depressive Disorder: Secondary Analysis of a Randomized Clinical Trial

December 24, 2019

The molecular and cellular mechanisms of depression: a focus on reward circuitry

«...2 345 6...»

650 Castro Street, Suite 450
Mountain View, CA 94041

Company

About
Leadership
Careers
Contact

Science

Platform
Publications
Pipeline

Investors

Overview
News
Events & Presentations
Stock Info
SEC Filings
Corporate Governance
Resources

Privacy Policy
Terms of Use
Accessibility
Cookie Policy

© 2024 Alto Neuroscience Inc. All rights reserved.

Scroll to Top